45
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Diagnostic Value of Liver Biopsy for Unexplained Liver Dysfunction: A Retrospective Study

, , &
Pages 2399-2407 | Received 19 Feb 2024, Accepted 15 Apr 2024, Published online: 17 May 2024

References

  • Zatoński WA, Sulkowska U, Mańczuk M, et al. Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe. Eur Addict Res. 2010;16(4):193–201. doi:10.1159/000317248
  • Peacock A, Leung J, Larney S, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905–1926. doi:10.1111/add.14234
  • World Health Organization. Global Hepatitis Report 2017. Geneva, Switzerland: World Health Organization; 2017.
  • Alberts CJ, Clifford GM, Georges D, et al. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol Hepatol. 2022;7(8):724–735. doi:10.1016/S2468-1253(22)00050-4
  • Liu Z, Lin C, Mao X, et al. Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people. Gut. 2023;72(12):2354–2363. doi:10.1136/gutjnl-2023-330691
  • Kouroumalis E, Voumvouraki A. Hepatitis C virus: a critical approach to who really needs treatment. World J Hepatol. 2022;14(1):1–44. doi:10.4254/wjh.v14.i1.1
  • Khalifa A, Rockey DC. The utility of liver biopsy in 2020. Curr Opin Gastroenterol. 2020;36(3):184–191. doi:10.1097/MOG.0000000000000621
  • Ramai D, Pannu V, Facciorusso A, et al. Advances in Endoscopic Ultrasound (EUS)-Guided Liver Biopsy. Diagnostics. 2023;13(4):784. doi:10.3390/diagnostics13040784
  • Ho LM, Pendse AA, Ronald J, et al. Comparison of clinical efficacy, subjective user experience, and safety for two different core biopsy needles, the Achieve® and Marquee®. Abdom Radiol. 2022;47(8):2632–2639. doi:10.1007/s00261-021-03187-5
  • Diehl DL. Endoscopic ultrasound-guided liver biopsy. Gastrointest Endosc Clin N Am. 2019;29(2):173–186. doi:10.1016/j.giec.2018.11.002
  • Sattar A, Khan AM, Anjum S, et al. Role of ultrasound guided fine needle aspiration cytology in diagnosis of space occupying lesions of liver. J Ayub Med Coll Abbottabad. 2014;26(3):334–336.
  • Chang Y, Kim JI, Lee B, et al. Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years. Clin Mol Hepatol. 2020;26(3):318–327. doi:10.3350/cmh.2019.0019n
  • Neuberger J, Patel J, Caldwell H, et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut. 2020;69(8):1382–1403. doi:10.1136/gutjnl-2020-321299
  • Chinese Society of Rheumatology of the Chinese Medical Association. Guidelines for diagnosis and management of autoimmune liver diseases. Chinese J Rheumatol. 2011;15(8):556–558. doi:10.3760/cma.j.issn.1007-7480.2011.08.011
  • Chinese Society of Hepatology of Chinese Medical Association, Chinese Society of Gastroenterology of Chinese Medical Association, and Chinese Society of Infectious Diseases of Chinese Medical Association. Expert consensus on the diagnosis and management of primary sclerosing cholangitis and cholestatic liver disease (2015). J Clin Hepatol. 2016;32(1):23–31. doi:10.3969/j.issn.1001-5256.2016.01.003
  • Chinese Society of Gastroenterology of Chinese Medical Association, and Chinese Society of Infectious Diseases of Chinese Medical Association. Consensus on the diagnosis and treatment of cholestasis liver diseases (2015). J Clin Hepatol. 2015;31(12):1989–1999. doi:10.3969/j.issn.1001-5256.2015.12.005
  • Drug-Induced Liver Disease Group under the Chinese Society of Hepatology of the Chinese Medical Association. Guidelines for the management of drug-induced liver injury. J Clin Hepatol. 2015;31(11):1752–1768. doi:10.3969/j.issn.1001-5256.2015.11.002
  • Fatty Liver and Alcoholic Liver Disease Group under the Chinese Society of Hepatology of the Chinese Medical Association, Fatty Liver Disease Expert Committee of the Chinese Medical Doctor Association. Guidelines of Prevention and Treatment for Nonalcoholic Fatty Liver Disease. J Mod Med Health. 2018;34(5):641–664.
  • Fatty Liver and Alcoholic Liver Disease Group under the Chinese Society of Hepatology of the Chinese Medical Association, Fatty Liver Disease Expert Committee of the Chinese Medical Doctor Association. Guidelines of prevention and treatment for alcoholic liver disease: a 2018 update. J Pract Hepatol. 2018;21(2):170–176. doi:10.3969/j.issn.1672-5069.2018.02.006
  • Chinese Society of Hepatology, Chinese Medical Association. 自身免疫性肝炎诊断和治疗指南 (2021) [Guidelines on the diagnosis and management of autoimmune hepatitis (2021)], Zhonghua Gan Zang Bing Za Zhi. 2022;30(5):482–492. Chinese. doi:10.3760/cma.j.cn112138-20211112-00796
  • National Center for Clinical Research of Infectious Diseases. 肝内胆汁淤积症诊治专家共识 (2021年版) [Expert consensus on the diagnosis and treatment of intrahepatic cholestasis (2021 edition)], Zhonghua Gan Zang Bing Za Zhi. 2022;30(2):137–146. Chinese. doi:10.3760/cma.j.cn501113-20220119-00033
  • European Association for the Study of the Liver. Electronic address: [email protected]; Clinical Practice Guideline Panel: Chair:; Panel members; EASL Governing Board representative. EASL Clinical Practice Guidelines: drug-induced liver injury. J Hepatol. 2019;70(6):1222–1261. doi:10.1016/j.jhep.2019.02.014
  • Pouwels S, Sakran N, Graham Y, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022;22(1):63. doi:10.1186/s12902-022-00980-1
  • Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association. Viral Hepatitis Prevention and Treatment Plan. Chin J Hepatol. 2009;8(6):324–329.
  • Palmer M. Guide to Hepatitis and Other Liver Diseases. Vol. 21. Niu J, Ding Y, Eds. Jilin People’s Publishing House; 2008:24–29.
  • Heo NY. [Epidemiology of autoimmune liver disease]. Korean J Gastroenterol. 2023;81(2):59–65. Korean. doi:10.4166/kjg.2023.007
  • Fan S, Yang L, Zhao R, et al. Comparative analysis of the 2022 edition of Chinese primary liver cancer diagnosis and treatment guidelines and the 2019 edition of diagnosis and treatment norms. Chin J Cancer Prevent Contr. 2022;29(22):1575–1578. doi:10.16073/j.cnki.cjcpt.2022.22.01
  • Cai Y, Jiang X, Xia YI, et al. Analysis of the value and safety of liver puncture for the diagnosis of unexplained liver disease. Nongkeng Med. 2021;43(04):324–327.
  • Ozeki Y, Kanogawa N, Ogasawara S, et al. Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis. Int J Clin Oncol. 2022;27(9):1459–1466. doi:10.1007/s10147-022-02195-9
  • Khalifa A, Lewin DN, Sasso R, Rockey DC. The utility of liver biopsy in the evaluation of liver disease and abnormal liver function tests. Am J Clin Pathol. 2021;156(2):259–267. doi:10.1093/ajcp/aqaa225
  • Björnsson HK, Björnsson ES. Drug-induced liver injury: pathogenesis, epidemiology, clinical features, and practical management. Eur J Intern Med. 2022;97:26–31. doi:10.1016/j.ejim.2021.10.035
  • Ahmad J, Barnhart HX, Bonacini M, et al.; Drug-Induced Liver Injury Network. Value of liver biopsy in the diagnosis of drug-induced liver injury. J Hepatol. 2022;76(5):1070–1078. doi:10.1016/j.jhep.2021.12.043
  • Andrade RJ, Chalasani N, Björnsson ES, et al. Drug-induced liver injury. Nat Rev Dis Primers. 2019;5(1):58. doi:10.1038/s41572-019-0105-0
  • Berardo C, Di Pasqua LG, Cagna M, et al. Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: current issues and future perspectives in preclinical and clinical research. Int J Mol Sci. 2020;21(24):9646. doi:10.3390/ijms21249646
  • Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851–1864. doi:10.1053/j.gastro.2020.01.052
  • Chaudhry H, Sohal A, Iqbal H, et al. Alcohol-related hepatitis: a review article. World J Gastroenterol. 2023;29(17):2551–2570. doi:10.3748/wjg.v29.i17.2551
  • Hunyady P, Herrmann E, Bojunga J, et al. Diagnostic value of a liver biopsy in patients with an acute liver failure or acute liver injury. Eur J Gastroenterol Hepatol. 2022;34(7):801–806. doi:10.1097/MEG.0000000000002382
  • Gilmore IT, Burroughs A, Murray-Lyon IM, et al. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut. 1995;36(3):437–441. doi:10.1136/gut.36.3.437
  • Androutsakos T, Dimitriadis K, Revenas K, et al. Liver biopsy: to do or not to do - a single-center study. Dig Dis. 2023;41(6):913–921. doi:10.1159/000533328